No Data
No Data
Nasdaq, ICE Get Outperform Ratings at RBC in New Exchange Coverage
CME Group: Navigating Competitive Pressures With a Strong Defensive Moat – A Hold Rating
RBC Capital Initiates CME Group(CME.US) With Hold Rating, Announces Target Price $235
CME Group Initiated With a Sector Perform at RBC Capital
TD Cowen Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $221
CME Group Inc. (NASDAQ:CME) Is Largely Controlled by Institutional Shareholders Who Own 89% of the Company
No Data
No Data